Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 281Genitourinary 129Other hematologic neoplasm 94Plasma cell 32Myeloid 13Dermatologic 10Sarcoma 9Thoracic 6Gastrointestinal 4CNS 4Breast 3Tumor-Agnostic 2Gynecologic 2Other neoplasm 1Head & Neck 1Endocrine 1

Conditions

Pituitary Neoplasms 1Craniopharyngioma 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Prednisone × Endocrine × Clear all
NCT02190994 2014-07-15

Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions

West China Hospital

Phase 4 Unknown
100 enrolled
CNSEndocrine

Craniopharyngioma, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡